What percentage of adult patients with 25-50% coronary artery disease (CAD) stenosis are expected to demonstrate ischemia by Fractional Flow Reserve (FFR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ischemia Prevalence in 25-50% Anatomical CAD by FFR

Lesions with 25-50% diameter stenosis rarely demonstrate hemodynamic significance by FFR, with the vast majority showing FFR values >0.80 and therefore not causing ischemia.

Evidence-Based Thresholds and Physiologic Significance

The relationship between anatomical stenosis severity and functional significance is well-established but highly variable in the intermediate range:

  • For stenoses <50% diameter, only 31-35% are hemodynamically significant by FFR measurement 1
  • The American College of Cardiology specifically defines intermediate lesions as 50-70% diameter stenosis, which require FFR assessment before intervention 1, 2
  • Stenoses in the 25-50% range fall below the traditional intermediate threshold and are generally not expected to cause flow-limiting ischemia 3

Specific Data on Mild Stenoses

The FAMOUS-NSTEMI trial provides the most direct evidence for your question:

  • This study specifically enrolled patients with stenoses ≥30% diameter (broader than typical trials that use ≥50% cutoffs) 3
  • The purpose was explicitly to provide data on the relationship between "mild" lesions and FFR 3
  • While exact percentages for the 25-50% subgroup are not reported, the study design acknowledges these lesions as "mild" and generally not flow-limiting 3

Clinical Decision Framework

For stenoses 25-50% diameter:

  • FFR measurement is generally not indicated as these lesions rarely cause ischemia 3, 1
  • The threshold for considering FFR assessment begins at 50% diameter stenosis (or 40% for some European guidelines) 3, 2
  • An FFR ≤0.80 defines hemodynamically significant stenosis, but this threshold is applied to intermediate (50-70%) or higher grade lesions 3, 2

Important Caveats

Serial stenoses create additive hemodynamic effects:

  • Multiple lesions each measuring <50% individually may collectively cause significant flow limitation 1
  • This represents a critical pitfall where visual assessment alone underestimates functional significance 1
  • In patients with diffuse disease or multiple mild lesions, FFR pullback tracings can identify cumulative ischemic burden 2

Practical Clinical Implications

The 25-50% stenosis range represents anatomically non-obstructive disease:

  • These patients should receive aggressive risk factor modification and optimal medical therapy 3
  • Revascularization of lesions without ischemia or FFR <0.80 is not recommended (Class III recommendation) 3
  • A normal functional test (including FFR >0.80) is associated with <1% annual rate of cardiac death and MI 3

References

Guideline

Cardiac CT Thresholds for Hemodynamically Significant Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Fractional Flow Reserve Determination During Cardiac Catheterization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the latest recommendation regarding CT-FFR (Computed Tomography-Fractional Flow Reserve) versus non CT-FFR approaches for diagnosing coronary artery disease and their impact on patient outcomes?
What is the best management plan for a middle-aged male with a history of coronary artery disease (CAD) status post percutaneous coronary intervention (PCI) x4, hyperlipidemia (HLD), and hypertension (HTN), who presents with increased chest pain, shortness of breath, and severe multivessel CAD, and is currently taking atorvastatin (Lipitor) and recently started on anticoagulation therapy due to blood clots?
What is the best physiologic tool to assess ischemia in a patient with a 50% mid-Left Anterior Descending (LAD) artery stenosis during Percutaneous Coronary Intervention (PCI)?
What are the considerations for a patient undergoing CT (Computed Tomography) coronary angiogram while on FFCT (likely referring to a chemotherapy regimen, possibly Fluorouracil, Fluorouracil, Cyclophosphamide, and Taxotere or similar)?
For a patient with newly diagnosed reduced Left Ventricular Ejection Fraction (LVEF), which diagnostic test is more suitable, a coronary Computed Tomography Angiography (CTA) with HeartFlow analysis or a nuclear stress test?
What are the next steps for a 9-year-old patient with a tic disorder and patent foramen ovale (PFO) who experiences chest pain and sweating after a clonidine (clonidine) dose increase?
What is the recommended treatment for a 14-year-old female patient with shingles?
Should a 34-year-old patient with hypertriglyceridemia and normal LDL cholesterol start fenofibrate to manage their lipid profile?
What is a suitable substitute for Thrombophob (Hirudin) ointment in a hemodialysis patient with End-Stage Renal Disease (ESRD) experiencing intense itching?
What is the management for intense itching in a patient with impaired renal function after applying Thrombophob (anticoagulant) ointment during hemodialysis?
What are the recommendations for using BPC (Body Protection Compound) 157 for treating musculoskeletal injuries or gastrointestinal issues?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.